Andreas Kjær and Carsten Haagen Nielsen

EY World Entrepreneur Of The Year™ 2026 finalists, Denmark
Andreas Kjær, Co-founder; and Carsten Haagen Nielsen, Co-founder and CEO; Minerva Imaging

Andreas Kjær and Carsten Haagen Nielsen are advancing precision radiotherapy in global oncology.

Photographic portrait of Andreas Kjær and Carsten Haagen Nielsen

Every year, around 20 million people are diagnosed with cancer worldwide. For nearly 60% of them, radiotherapy is part of the journey. Yet for decades, one of oncology’s most widely used treatments has remained imprecise and invasive.

It was this gap that led physician and researcher Andreas Kjær and entrepreneur Carsten Haagen Nielsen to start Minerva Imaging in 2011. Long before targeted radionuclide therapy captured global attention, they saw its potential to change how radiotherapy is delivered and set out to make that future possible.

Together, they have grown Minerva Imaging into a fully integrated organization supporting pharmaceutical and biotech companies across the drug development journey. By removing critical bottlenecks in research, manufacturing and regulation, they help accelerate access to safer, more precise cancer treatments. What began as a scientific spinout is now a global life sciences company with GMP certification, worldclass facilities and consistent above-market growth.

Today, Andreas and Carsten are building long-term value by strengthening the ecosystem around targeted radionuclide therapy — investing in infrastructure, talent and partnerships that will shape cancer care for decades. Minerva Imaging is not just scaling; it is enabling better treatment options and offering more patients real hope.

As a physician, you focus on individual patients; as an entrepreneur, you can improve outcomes for millions of patients over time.